v3.26.1
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 11,648 $ 13,712
General and administrative 5,256 4,398
Total operating expenses 16,904 18,110
Loss from operations (16,904) (18,110)
Other income (expense):    
Interest income 2,505 2,250
Other expense, net (57) (130)
Total other income, net 2,448 2,120
Net loss (14,456) (15,990)
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities (513) 99
Comprehensive loss $ (14,969) $ (15,891)
Net loss per share, basic (in dollars per share) [1] $ (0.39) $ (0.62)
Net loss per share, diluted (in dollars per share) [1] $ (0.39) $ (0.62)
Weighted-average shares of common shares outstanding, basic (in shares) 37,339,026 25,868,935
Weighted-average shares of common shares outstanding, diluted (in shares) 37,339,026 25,868,935
[1] Basic and diluted per share amounts are the same for Class A and Class B shares.